Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | ESR1 | P03372 | 1/20 | 0.58 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.58 |
| ▸ | CDC25A | P30304 | 1/20 | 0.58 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.58 |
| ▸ | AKT1 | P31749 | 1/20 | 0.58 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | CETP | P11597 | 3/20 | 0.50 |
| ▸ | FABP3 | P05413 | 1/20 | 0.49 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.47 |
| ▸ | LPAR2 | Q9HBW0 | 3/20 | 0.47 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.47 |
| ▸ | PTAFR | P25105 | 1/20 | 0.47 |
| ▸ | HTR1D | P28221 | 1/20 | 0.47 |
| ▸ | HTR2C | P28335 | 1/20 | 0.47 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
| ▸ | TMEM97 | Q5BJF2 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14000864 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL21580898 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL19458808 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL27699112 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL20482670 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL20483366 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL12235520 | 1.00 | LMNA (0.58) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL28786169 | 0.98 | LMNA (0.56) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL29267508 | 0.91 | LPAR3 (0.53) | LMNAESR1ADORA3CDC25AAGTR1 | |
| SCHEMBL27747029 | 0.91 | LPAR3 (0.53) | LMNAESR1ADORA3CDC25AAGTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-105832658-B | Stable formulations of insulinotropic peptides | 诺和诺德公司 | 2020-07-31 | — | — | CN | disclosed |
| CN-107735430-A | Method for producing rubber particles bonded to membrane-bound protein, method for producing pneumatic tire, and method for producing rubber product | 住友橡胶工业株式会社 | 2018-02-23 | — | — | CN | disclosed |
| CN-107709565-A | Polyisoprenoid, vector, method for producing transgenic plant, method for producing pneumatic tire, and method for producing rubber product | 住友橡胶工业株式会社 | 2018-02-16 | — | — | CN | disclosed |
| CN-106137952-A | The stabilization formulations of insulinoptropic peptides | 诺和诺德公司 | 2016-11-23 | — | — | CN | disclosed |
| CN-105832658-A | Stable formulations of insulinoptropic peptides | 诺和诺德公司 | 2016-08-10 | — | — | CN | disclosed |
| CN-101842109-B | Peptides derivatized with A-B-C-D- and their therapeutical use | NOVO NORDISK AS | 2014-01-29 | — | — | CN | disclosed |
| CN-103124739-A | Novel glucagon like peptide analogs, composition, and method of use | ZHEJIANG BETA PHARMA INC | 2013-05-29 | — | — | CN | disclosed |
| CN-101854914-B | Stable formulations of amylin and analogs thereof | NOVO NORDISK AS | 2013-03-27 | — | — | CN | disclosed |
| CN-102772787-A | Stable formulations of insulinoptropic peptides | NOVO NORDISK COMPANY | 2012-11-14 | — | — | CN | disclosed |
| CN-102027007-A | Long acting Y2 and/or Y4 receptor agonists | NOVO NORDISK AS | 2011-04-20 | — | — | CN | disclosed |
| CN-101868476-A | Glucagon-like peptide-1 derivatives and their pharmaceutical use | NOVO NORDISK AS | 2010-10-20 | — | — | CN | disclosed |
| CN-101854914-A | Stable formulations of amylin and analogs thereof | NOVO NORDISK AS | 2010-10-06 | — | — | CN | disclosed |
| CN-101842386-A | Truncated GLP-1 derivatives and their therapeutic uses | NOVO NORDISK AS | 2010-09-22 | — | — | CN | disclosed |
| CN-101842109-A | Peptides derivatized with A-B-C-D- and their therapeutical use | NOVO NORDISK AS | 2010-09-22 | — | — | CN | disclosed |
| CN-101128214-A | Extended GLP-1 compounds | NOVO NORDISK AS (DK) | 2008-02-20 | — | — | CN | disclosed |
| CN-101056650-A | Stable formulations of insulinotropic peptides | NOVO NORDISK AS (DK) | 2007-10-17 | — | — | CN | disclosed |
| CN-1311438-A | Method and reagent for measuring C-reactive protein | KYOWA MEDIX CO LTD (JP) | 2001-09-05 | — | — | CN | disclosed |